NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 17 in the first quarter as part of a restructuring plan, it said in its Form 10-Q this week. The company recognized pre-tax restructuring charges of $400,000 and $200,000 in its Human Health segment and Environmental Health segment, respectively, as a result. PerkinElmer also shut down its Signature Genomics business subsequent to the end of the first quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.